Myocardial protection via the coronary sinus - Long-term effects of intermittent coronary sinus occlusion as an adjunct to reperfusion in acute myocardial infarction

Circulation Journal

Volumn 72, Issue 4, 2008, Pages 526-533

  Mohl, Werner ^a   Komamura, Kazuo ^b   Kasahara, Hirofumi ^a   Heinze, Georg ^a   Glogar, Dietmar ^a   Hirayama, Atsushi ^c   Kodama, Kazuhisa ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Coronary sinus interventions; Myocardial infarction; Pressure controlled intermittent coronary sinus occlusion (PICSO)

Indexed keywords

CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROL GROUP; CONTROLLED STUDY; CORONARY SINUS; DATA ANALYSIS; DATA COLLECTION METHOD; FEMALE; FOLLOW UP; HEART PROTECTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; REPERFUSION; REVASCULARIZATION; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

AGED; CORONARY RESTENOSIS; CORONARY SINUS; CREATINE KINASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 43549100410     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.526     Document Type: Article

References (36)

1. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004; 110: 3055-3061.
2. Mohl W. The momentum of coronary sinus interventions clinically. Circulation 1988; 77: 6-12.
3. Syeda B, Schukro C, Heinze G, Modaressi K, Glogar D, Maurer G, et al. The salvage potential of coronary sinus interventions: Meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg 2004; 127: 1703-1712.
4. Mohl W, Simon P, Neumann F, Schreiner W, Punzengruber C. Clinical evaluation of pressure-controlled intermittent coronary sinus occlusion: Randomized trial during coronary artery surgery. Ann Thorac Surg 1988; 46: 192-201.
5. Komamura K, Mishima M, Kodama K. Preliminary clinical experience with intermittent coronary sinus occlusion in combination with thrombolytic therapy in acute myocardial infarction. Jpn Circ J 1989; 53: 1152-1163.
6. Incorvati RL, Tauberg SG, Pecora MJ, Macherey RS, Krucoff MW, Dianzumba SB, et al. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993; 22: 127-134.
7. Boekstegers P, Giehrl W, von Degenfeld G, Steinbeck G. Selective suction and pressure-regulated retroinfusion: An effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1998; 31: 1525-1533.
8. Mangano DT, Miao Y, Tudor IC, Dietzel C. Post-reperfusion myocardial infarction: Long-term survival improvement using adenosine regulation with acadesine. J Am Coll Cardiol 2006; 48: 206-214.
9. Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, et al. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J 2006; 70: 1099-1104.
10. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study. J Thorac Cardiovasc Surg 2005; 130: 1631-1638.
11. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
12. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971; 50: 2614-2625.
13. Norris RM, Whitlock RM, Barratt-Boyes C, Small CW. Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation 1975; 51: 614-620.
14. Feild BJ, Russell RO Jr, Dowling JT, Rackley CE. Regional left ventricular performance in the year following myocardial infarction. Circulation 1972; 46: 679-689.
15. Gelberg HJ, Brundage BH, Glantz S, Parmley WW. Quantitative left ventricular wall motion analysis: A comparison of area, chord and radial methods. Circulation 1979; 59: 991-1000.
16. Prigent F, Maddahi J, Garcia EV, Satoh Y, Van Train K, Berman DS. Quantification of myocardial infarct size by thallium-201 single-photon emission computed tomography: Experimental validation in the dog. Circulation 1986; 74: 852-861.
17. Caldwell JH, Williams DL, Harp GD, Stratton JR, Ritchie JL. Quantitation of size of relative myocardial perfusion defect by single-photon emission computed tomography. Circulation 1984; 70: 1048-1056.
18. Wagner GS, Freye CJ, Palmeri ST, Roark SF, Stack NC, Ideker RE, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. I: Specificity and observer agreement. Circulation 1982; 65: 342-347.
19. Heinze G, Gnant M, Schemper M. Exact log-rank tests for unequal follow-up. Biometrics 2003; 59: 1151-1157.
20. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001; 57: 114-119.
21. Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ 2001: 323: 1123-1124.
22. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999; 100: 14-20.
23. Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase IIA trial. Circulation 1990; 81: 1457-1476.
24. Zhan R, Schiele R, Schneider S, Gitt AK, Heer T, Wienbergen H, et al. Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis: Results of the MITRA trial. Z Kardiol 2002; 91: 49-57 (in German with English abstract).
25. Henriques JP, Zijlstea F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink AT, et al. Primary percutaneous coronary intervention versus thrombolytic treatment: Long term follow up according to infarct location. Heart 2006; 92: 75-79.
26. Kasahara H, Komamura K, Glogar D, Kodama K, Hirayama A, Mohl W. Do long term effects after PICSO endorse the potential of cardiac regeneration after acute myocardial infarction? Wien Klin Wochenschr 2007; 119(Suppl): 23-26.
27. Weigel G, Kajgana I, Bergmeister H, Riedl G, Glogar HD, Gyongyosi M, et al. Beck and back: A paradigm change in coronary sinus interventions-pulsatile stretch on intact coronary venous endothelium. J Thorac Cardiovasc Surg 2007; 133: 1581-1587.
28. Mohl W. Embryonic recall: Myocardial regeneration beyond stem cell transplantation. Wien Klin Wochenschr 2007; 119: 333-336.
29. Seko Y, Takahashi N, Shibuya M, Yazaki Y. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun 1999; 254: 462-465.
30. Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, et al. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 2003; 95: 2081-2088.
31. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-1720.
32. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
33. Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning: A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005; 112: 2085-2088.
34. Yip HK, Youssef AA, Chang LT, Yang CH, Sheu JJ, Chua S, et al. Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circ J 2007; 71: 1086-1091.
35. Libby P, Ridker PM. Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. Am J Med 2004; 116(Suppl 6A): 9S-16S.
36. Hong YJ, Jeong MH, Lim SY, Lee SR, Hong SN, Kim KH, et al. Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. Am J Cardiol 2006; 98: 341-345.